This page shows the latest CPI news and features for those working in and with pharma, biotech and healthcare.
In cohort one, which assessed mUC patients whose cancer had progressed after platinum-based chemotherapy and checkpoint inhibitor therapy (CPI), Trodelvy was associated with a 10.9 months median overall survival, ... Cohort two, which included
MorphoSys will pay $34 a share to acquire Constellation Pharma, which will see it gain two lead drugs, including BET inhibitor pelabresib and second-generation EZH2 inhibitor CPI-0209. ... 100% of future milestone payments on pipeline product otilimab, 60
CPI), part of the UK government’s network of High Value Manufacturing Catapult centres. ... As an existing client of Notch Communications, CPI will receive a custom communications plan comprising of social media assistance, press releases, case studies,
by helping to speed innovations that make medicines and foods more effective, safer and more affordable' led to the development of its 'Critical Path Initiative' (CPI), with the explicit aim of ... Resources are finite, however, and the industry's
According to a recent US study by Prospectiv, MarketingCharts, approximately 75 per cent of consumers surveyed by Prospectiv's 2007 Pharmaceutical Marketing CPI poll say they view the internet as their ... According to a recent US study by Prospectiv,
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
The designation of the baseline quarter for AMP and CPI-U is contingent upon the market entry date of the product. ... After this point, the corresponding values for Baseline AMP and CPI-U should be retrieved so that data can be prepared for the amendment
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
The company has established a clear path to registration for its two lead clinical development programmes - CPI-1205 in solid tumours and CPI-0610 in a molecularly defined and prospectively selected ... activities across CPI-1205 and the company’s next
Mike Davies joins from CPI Biologics. Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site. ... Davies has over 15 years of experience the development,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
No results were found
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...